Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersLloyd Paul Aiello, George L. King, Robert L. Avery et al.|New England Journal of Medicine|1994Cited by 3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.Lloyd Paul Aiello, Lois E. H. Smith, Eric A. Pierce et al.|Proceedings of the National Academy of Sciences|1995Cited by 1.3k
Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β InhibitorHidehiro Ishii, George L. King, Michael R. Jirousek et al.|Science|1996Cited by 1.1k
Retinopathy in DiabetesDonald S. Fong, Ronald Klein, Lloyd Paul Aiello et al.|Diabetes Care|2004Cited by 1.1k
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic ComplicationsPedro Geraldes, George L. King|Circulation Research|2010Cited by 979